Empowerment

Early Real-World Outcomes with Filgotinib in Patients with Ulcerative Colitis: A Prospective, Observational Study (GALOCEAN)

October 2024

This study investigates the real-world effectiveness of Filgotinib (FIL), an oral JAK1 preferential inhibitor, in patients with ulcerative colitis (UC). While the clinical efficacy of FIL has been established in the SELECTION trial, real-world data has been limited.

Read time: 1 min

Empowering Patient Voices in Health Technology Assessment: EFCCA's Conference at UEG Week 2024

On 12 October 2024, EFCCA organised a conference during UEG Week (Vienna) titled: "How can patients play a crucial role in medicines-related decision-making? An open dialogue with stakeholders and the presentation of the EFCCA HTA Guidebook."

Read time: 2 mins

EFCCA Magazine 3/2024

New look and new issue of the EFCCA Magazine!
Issue 3 - October 2024

We’re excited to present the latest issue of the EFCCA Magazine, now with a refreshed design! Inside, you’ll find an exclusive interview with Professor James Lee, who shares insights on his groundbreaking research into the causes of Inflammatory Bowel Disease (IBD).

Read time: 1 min

EFCCA Magazine 2/2024

We’re excited to share our latest edition of the EFCCA Magazine! Discover how EFCCA and its members are making a difference locally and globally, from raising IBD awareness through impactful campaigns advocating for improved healthcare policies. Learn more about our partnerships involving the European Association of Hospital Pharmacists (EAHP), founding members and sister patient organisations of World IBD Day and our involvement in the EU Cross Border Clinical Trials Initiative (EU-X-CT Initiative).

Read time: 1 min

EFCCA Magazine 2/2024

We’re excited to share our latest edition of the EFCCA Magazine! Discover how EFCCA and its members are making a difference locally and globally, from raising IBD awareness through impactful campaigns advocating for improved healthcare policies.

Read time: 1 min

Patient Preferences

There is very little scientific evidence on patient preference targeted at the IBD patient community.

Read time: 3 mins

"IBD Dialogues: Building Generations" EFCCA Conference at ECCO'24 Congress

EFCCA organised the conference "IBD Dialogues: Building Generations" held on 22 February at the ECCO'24 Congress in Stockholm presenting the preliminary results of our study on people with IBD aged +60, which EFCCA carried out together with Leiden University Medical Center.

Read time: 2 mins

EFCCA Magazine 1/2024

We’re excited to share this year's first edition of the EFCCA magazine!

Thanks to all contributors for making this publication possible!

Read time: 1 min

EFCCA Empowerment Academy

We launched our EFCCA Empowerment Academy, a training programme tailored for recent EFCCA members designed to offer deeper insights into the organisation and provide participants with a learning journey led by EFCCA staff and other experts.

Read time: 2 mins

EFCCA Magazine 1/2024

We’re excited to share this year's first edition of the EFCCA magazine!

- Read our interview with R. Campanella, as he shares his patient perspective from the 3rd ECCO Council Meeting which gathered national representatives from the patient and ECCO community

- Discover the news from our members, sharing their stories and experiences.

Read time: 1 min

Early Real-World Outcomes with Filgotinib in Patients with Ulcerative Colitis: A Prospective, Observational Study (GALOCEAN)

New look and new issue of the EFCCA Magazine! Issue 3 - October 2024

New look and new issue of the EFCCA Magazine!
Issue 3 - October 2024